Pharmacogenomics
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders
Brain Sci. 2022 Dec 4;12(12):1666. doi: 10.3390/brainsci12121666.
NO ABSTRACT
PMID:36552127 | DOI:10.3390/brainsci12121666
Pharmacogenetics and Schizophrenia-Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
Biomedicines. 2022 Dec 7;10(12):3165. doi: 10.3390/biomedicines10123165.
NO ABSTRACT
PMID:36551925 | DOI:10.3390/biomedicines10123165
Methylenetetrahydrofolate Reductase C677T Gene Variant in Relation to Body Mass Index and Folate Concentration in a Polish Population
Biomedicines. 2022 Dec 6;10(12):3140. doi: 10.3390/biomedicines10123140.
NO ABSTRACT
PMID:36551896 | DOI:10.3390/biomedicines10123140
Transcription Factors and ncRNAs Associated with <em>CYP3A</em> Expression in Human Liver and Small Intestine Assessed with Weighted Gene Co-Expression Network Analysis
Biomedicines. 2022 Nov 28;10(12):3061. doi: 10.3390/biomedicines10123061.
NO ABSTRACT
PMID:36551817 | DOI:10.3390/biomedicines10123061
Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series
Antibiotics (Basel). 2022 Dec 16;11(12):1830. doi: 10.3390/antibiotics11121830.
NO ABSTRACT
PMID:36551485 | DOI:10.3390/antibiotics11121830
Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients
Biomolecules. 2022 Dec 10;12(12):1845. doi: 10.3390/biom12121845.
NO ABSTRACT
PMID:36551272 | DOI:10.3390/biom12121845
GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels
Brief Bioinform. 2022 Dec 22:bbac558. doi: 10.1093/bib/bbac558. Online ahead of print.
NO ABSTRACT
PMID:36549921 | DOI:10.1093/bib/bbac558
Introducing HL7 FHIR Genomics Operations: a developer-friendly approach to genomics-EHR integration
J Am Med Inform Assoc. 2022 Dec 22:ocac246. doi: 10.1093/jamia/ocac246. Online ahead of print.
NO ABSTRACT
PMID:36548217 | DOI:10.1093/jamia/ocac246
Comparison of maintenance dose predictions by warfarin dosing algorithms based on Chinese and Western patients
J Clin Pharmacol. 2022 Dec 22. doi: 10.1002/jcph.2197. Online ahead of print.
NO ABSTRACT
PMID:36546564 | DOI:10.1002/jcph.2197
Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study
Front Pharmacol. 2022 Dec 5;13:1032995. doi: 10.3389/fphar.2022.1032995. eCollection 2022.
NO ABSTRACT
PMID:36545312 | PMC:PMC9760790 | DOI:10.3389/fphar.2022.1032995
Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: Perspectives in pharmacogenomics
Front Pharmacol. 2022 Dec 5;13:1078766. doi: 10.3389/fphar.2022.1078766. eCollection 2022.
NO ABSTRACT
PMID:36545311 | PMC:PMC9760816 | DOI:10.3389/fphar.2022.1078766
Inclusion of the in-chain sulfur in 3-thiaCTU increases the efficiency of mitochondrial targeting and cell killing by anticancer aryl-urea fatty acids
Eur J Pharmacol. 2022 Dec 18:175470. doi: 10.1016/j.ejphar.2022.175470. Online ahead of print.
NO ABSTRACT
PMID:36543287 | DOI:10.1016/j.ejphar.2022.175470
Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone
Arch Pharm Res. 2022 Dec 21. doi: 10.1007/s12272-022-01422-1. Online ahead of print.
NO ABSTRACT
PMID:36542291 | DOI:10.1007/s12272-022-01422-1
Development and application of a computable genotype model in the GA4GH Variation Representation Specification
BaySyn: Bayesian Evidence Synthesis for Multi-system Multiomic Integration
Leveraging Multi-Ancestry Polygenic Risk Scores for Body Mass Index to Predict Antiretroviral Therapy-Induced Weight Gain
The Role of Global and Local Ancestry on Clopidogrel Response in African Americans
Escitalopram Induced Angioedema
Cureus. 2022 Nov 17;14(11):e31600. doi: 10.7759/cureus.31600. eCollection 2022 Nov.
NO ABSTRACT
PMID:36540519 | PMC:PMC9758958 | DOI:10.7759/cureus.31600
Pharmacogenomic markers of glucocorticoid response in congenital adrenal hyperplasia
PLoS One. 2022 Dec 20;17(12):e0279298. doi: 10.1371/journal.pone.0279298. eCollection 2022.
NO ABSTRACT
PMID:36538565 | DOI:10.1371/journal.pone.0279298
The humanized CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia
Neuropathol Appl Neurobiol. 2022 Dec 19:e12867. doi: 10.1111/nan.12867. Online ahead of print.
NO ABSTRACT
PMID:36536486 | DOI:10.1111/nan.12867